{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:15:58Z","timestamp":1791951358064,"version":"4.3.4"},"reference-count":28,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GeneScience Pharmaceutical Co Ltd"},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS Research Scotland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Although the safety and effectiveness of recombinant human growth hormone therapy (rhGH) has been reported for several years, the level of consensus on the outcomes that should be reported is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aims to understand the frequency and trends in reported outcomes of safety and effectiveness for rhGH therapy for growth hormone deficiency (GHD) in childhood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was performed in 7 English- and Chinese-language databases. Eligibility criteria included all studies published between 2003 and 2022, with participants who started rhGH before age 16 years for GHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 219 eligible studies that were identified included 171 cohort studies, 39 controlled trials, and 9 case-control studies. The median age of the participants at start of rhGH was 9.5 years (10th-90th: 7.1-11.9). The most commonly reported outcomes included change in height SDS in 117 (53%), height velocity in 105 (48%), insulin-like growth factor-1 (IGF-1) in 66 (30%), height in 63 (29%), bone age in 58 (26%), IGF-1 SDS in 45 (21%), injection site adverse events in 44 (20%), glucose concentration in 42 (19%), insulin-like growth factor-binding protein 3 in 34 (16%), and thyroid function in 30 (14%). Of the 342 different outcomes, 178 (52%) were considered as outcomes that were mainly focused on safety, 94 (28%) on efficacy, and 70 (20%) on both. Over the two decades, height SDS and height velocity remained the most frequently reported outcomes. Of the 342 outcomes, 9 (3%) were on quality of life and these were reported in 29 of 219 (13%) studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of this systematic review allow the development of a core outcome set that is recommended for routine use in all children receiving rhGH for childhood GHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf500","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T11:51:31Z","timestamp":1756986691000},"page":"e837-e843","source":"Crossref","is-referenced-by-count":3,"title":["Trends In Reported Outcomes for Growth Hormone Therapy In Children With Growth Hormone Deficiency"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-8695","authenticated-orcid":false,"given":"Xanthippi","family":"Tseretopoulou","sequence":"first","affiliation":[{"name":"Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children , Glasgow G51 4TF ,","place":["UK"]},{"name":"Office for Rare Conditions, University of Glasgow , Glasgow G51 4TF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health , Beijing 100044 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lucas-Herald","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children , Glasgow G51 4TF ,","place":["UK"]},{"name":"Office for Rare Conditions, University of Glasgow , Glasgow G51 4TF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Charmandari","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, \u2018Aghia Sophia\u2019 Children's Hospital , Athens 11527 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine , Seoul 05505 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Dou","sequence":"additional","affiliation":[{"name":"Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health , Beijing 100044 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Hamza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Endocrinology Unit, Ain Shams University , Cairo 1181 ,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Harvey","sequence":"additional","affiliation":[{"name":"MAGIC Foundation , Warrenville, IL 60555 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0145-1917","authenticated-orcid":false,"given":"Andrew R","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Metabolism and Gerontology, Stanford University School of Medicine , Stanford, CA 94305 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3429-3246","authenticated-orcid":false,"given":"Reiko","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, National Center for Child Health and Development , Tokyo 157-8535 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Department of Endocrinology, Sahlgrenska University Hospital , Gothenburg 413 45 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Augusto","family":"de Lima Jorge","sequence":"additional","affiliation":[{"name":"Genetic-Endocrinology Unit, Endocrinology Division of Hospital das Clinicas of University of S\u00e3o Paulo School of Medicine , S\u00e3o Paulo 05403 010 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley S","family":"Miller","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School, MHealth Fairview Masonic Children's Hospital , Minneapolis, MN 55455 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pietropoli","sequence":"additional","affiliation":[{"name":"Novo Nordisk Health Care AG, Global Medical Affairs Rare Endocrine Disorders , Zurich CH-8058 ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-4976","authenticated-orcid":false,"given":"Lars","family":"S\u00e4vendahl","sequence":"additional","affiliation":[{"name":"Department of Women\u00b4s and Children's Health, Karolinska Institutet and Karolinska University Hospital , Stockholm SE-17177 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Vitali","sequence":"additional","affiliation":[{"name":"SOD Italia , Rome 11-00198 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wajnrajch","sequence":"additional","affiliation":[{"name":"Pfizer Biopharmaceuticals, Rare Disease, Department of Pediatrics, New York University Langone Medical Center , New York, NY 10001-2192 ,","place":["USA"]},{"name":"New York University Langone Medical Center , New York, NY 10016 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet Ching","family":"Chen","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children , Glasgow G51 4TF ,","place":["UK"]},{"name":"Office for Rare Conditions, University of Glasgow , Glasgow G51 4TF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiu","family":"Gong","sequence":"additional","affiliation":[{"name":"Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health , Beijing 100044 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-5549","authenticated-orcid":false,"given":"S Faisal","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children , Glasgow G51 4TF ,","place":["UK"]},{"name":"Office for Rare Conditions, University of Glasgow , Glasgow G51 4TF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"2026021918530271100_dgaf500-B1","doi-asserted-by":"crossref","first-page":"720419","DOI":"10.3389\/fendo.2021.720419","article-title":"Short and long-term effects of growth hormone in children and adolescents with GH deficiency","volume":"12","author":"Ranke","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026021918530271100_dgaf500-B2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1515\/jpem.2010.092","article-title":"Systematic review of the clinical effectiveness of genotropin (somatropin) in children with short stature","volume":"23","author":"Loftus","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2026021918530271100_dgaf500-B3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1210\/jcem-18-8-901","article-title":"Treatment of a pituitary dwarf with human growth hormone","volume":"18","author":"Raben","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026021918530271100_dgaf500-B4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/apa.15948","article-title":"The history, physiology and treatment safety of growth hormone","volume":"111","author":"Tidblad","year":"2022","journal-title":"Acta Paediatr"},{"issue":"5","key":"2026021918530271100_dgaf500-B5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000322878","article-title":"A comparison of different definitions of growth response in short prepubertal children treated with growth hormone","volume":"75","author":"Bang","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2026021918530271100_dgaf500-B6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ghir.2017.12.006","article-title":"GH and GHR signaling in human disease","volume":"38","author":"Guevara-Aguirre","year":"2018","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"2026021918530271100_dgaf500-B7","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026021918530271100_dgaf500-B8","doi-asserted-by":"crossref","first-page":"811846","DOI":"10.3389\/fendo.2021.811846","article-title":"Safety of pediatric rhGH therapy: an overview and the need for long-term surveillance","volume":"12","author":"Cianfarani","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2026021918530271100_dgaf500-B9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S2213-8587(20)30163-7","article-title":"Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study","volume":"8","author":"Savendahl","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2026021918530271100_dgaf500-B10","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026021918530271100_dgaf500-B11","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/clinem\/dgac513","article-title":"Weekly somapacitan is effective and well tolerated in children with GH deficiency: the randomized phase 3 REAL4 trial","volume":"107","author":"Miller","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026021918530271100_dgaf500-B12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000533763","article-title":"Development of a minimum dataset for the monitoring of recombinant human growth hormone therapy in children with growth hormone deficiency: a GloBE-reg initiative","volume":"97","author":"Chen","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"2026021918530271100_dgaf500-B13","doi-asserted-by":"publisher","author":"Tseretopoulou","DOI":"10.5525\/gla.researchdata.2036"},{"issue":"8","key":"2026021918530271100_dgaf500-B14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11136-009-9528-5","article-title":"Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments","volume":"18","author":"Terwee","year":"2009","journal-title":"Qual Life Res"},{"issue":"3","key":"2026021918530271100_dgaf500-B15","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"2026021918530271100_dgaf500-B16","doi-asserted-by":"crossref","first-page":"795224","DOI":"10.3389\/fendo.2022.795224","article-title":"Treatment adherence to injectable treatments in pediatric growth hormone deficiency compared with injectable treatments in other chronic pediatric conditions: a systematic literature review","volume":"13","author":"Gomez","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026021918530271100_dgaf500-B17","doi-asserted-by":"crossref","first-page":"e0264403","DOI":"10.1371\/journal.pone.0264403","article-title":"Pediatric growth hormone treatment in Italy: a systematic review of epidemiology, quality of life, treatment adherence, and economic impact","volume":"17","author":"Orso","year":"2022","journal-title":"PLoS One"},{"key":"2026021918530271100_dgaf500-B18","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019","edition":"2nd Edition"},{"issue":"6","key":"2026021918530271100_dgaf500-B19","doi-asserted-by":"crossref","first-page":"e99111","DOI":"10.1371\/journal.pone.0099111","article-title":"Choosing important health outcomes for comparative effectiveness research: a systematic review","volume":"9","author":"Gargon","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"2026021918530271100_dgaf500-B20","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society","volume":"85","author":"Growth Hormone Research Society","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026021918530271100_dgaf500-B21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.2012.04420.x","article-title":"Identification and management of poor response to growth-promoting therapy in children with short stature","volume":"77","author":"Bang","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026021918530271100_dgaf500-B22","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-19-0458","article-title":"IGF-1 and IGF-1 SDS\u2014fit for purpose?","volume":"181","author":"Kos","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026021918530271100_dgaf500-B23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1515\/jpem-2015-0423","article-title":"Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency","volume":"29","author":"Ciresi","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026021918530271100_dgaf500-B24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fendo.2018.00321","article-title":"Glucose metabolism in children with growth hormone deficiency","volume":"9","author":"Ciresi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026021918530271100_dgaf500-B25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12020-024-03938-6","article-title":"A comprehensive systematic review of health-related quality of life measures in short stature paediatric patients","volume":"86","author":"Adedeji","year":"2024","journal-title":"Endocrine"},{"issue":"4","key":"2026021918530271100_dgaf500-B26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/eahr.500216","article-title":"Patient-reported outcome measures in routine clinical practice: practical guidance for institutional review boards","volume":"46","author":"Bachmann","year":"2024","journal-title":"Ethics Hum Res"},{"issue":"2","key":"2026021918530271100_dgaf500-B27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/jmrs.421","article-title":"A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care","volume":"68","author":"Nguyen","year":"2021","journal-title":"J Med Radiat Sci"},{"issue":"1","key":"2026021918530271100_dgaf500-B28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","author":"Murray","year":"2016","journal-title":"Arch Dis Child"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf500\/64215954\/dgaf500.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e837\/64215954\/dgaf500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/3\/e837\/64215954\/dgaf500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:53:12Z","timestamp":1771545192000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/3\/e837\/8248597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,5]]},"published-print":{"date-parts":[[2026,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf500","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,9,5]]}}}